A.S.P.E.N. Publishes Parenteral Nutrition Safety Supplement

FOR IMMEDIATE RELEASE
March 16, 2012


Silver Spring, MD – Recent safety concerns in the preparation and delivery of parenteral nutrition (PN), commonly referred to as intravenous (IV) nutrition, prompted leaders from several major organizations to participate in the A.S.P.E.N. PN Safety Summit in September 2011. Proceedings from the Summit are now published in a supplement to the March issue of A.S.P.E.N.’s Journal of Parenteral & Enteral Nutrition (JPEN).

The A.S.P.E.N. PN Safety Summit, endorsed by the Institute of Safe Medication Practices (ISMP) and sponsored by Baxter, brought together 46 key stakeholders to identify processes to improve the safety of prescribing, formulating, and delivering PN to patients across a variety of healthcare. The Summit’s purpose was to bring focus to PN safety issues and then develop action items and recommendations to make this therapy safer. When these therapies are not
prepared with quality control measures in place, the sterility, stability and compatibility can be impacted, putting patients at risk. Preparing parenteral nutrition involves complex sterile preparations and should be handled in a carefully controlled environment with built-in quality assurance from prescribing, to formulating and delivery. 

“Shortly after the PN Safety Summit, the A.S.P.E.N. Board of Directors appointed a PN Safety Task Force to prioritize and address many of the issues, recommend actions, and set up a plan to make real change,” said Jay Mirtallo, A.S.P.E.N. president. “The content in this PN safety supplement will help healthcare providers provide better patient care to all who receive PN.” 


Sample content from the Parenteral Nutrition Safety Supplement includes reports on: 
• Safe practices for PN, including prescribing, order review and verification, and compounding
• Safety surrounding PN systems, including types of errors reported 
• Prescribing PN safely using a standardized process 
• PN prescribing processes using computerized prescriber order entry 
• Issues surrounding compounding of PN including use of USP <797> 
• The role of commercially prepared PN products 

The supplement is delivered free of charge to A.S.P.E.N. members and to JPEN subscribers. Journalists interested in reviewing the supplement should contact [email protected]

******

The American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) is dedicated to
improving patient care by advancing the science and practice of clinical nutrition and 
metabolism. Founded in 1976, A.S.P.E.N. is an interdisciplinary organization whose members 
are involved in the provision of clinical nutrition therapies, including parenteral and enteral 
nutrition. With more than 5,500 members from around the world, A.S.P.E.N. is a community of 
dietitians, nurses, pharmacists, physicians, scientists, students and other health professionals 
from every facet of nutrition support clinical practice, research and education. 
 
###